XORTX Therapeutics Inc. (XRTX)
NCM · Common · CUSIP 98420Q306
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XRTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
98420Q306
Market Cap
Micro Cap
Previous Symbol
XRTXD (changed 10/13/2021)
Business: XORTX Therapeutics Inc. is a biopharmaceutical company working to advance its clinical development stage products that target xanthine oxidase to inhibit production of uric acid. The Company has intellectual property rights and established proof of concept through independent clinical studies.

Company Contact

CEO
Allen W. Davidoff
CFO
James Fairbairn
Headquarters
Suite 4000, 421, 7th Avenue SW, Calgary, Alberta, Canada T2P 4K9
Phone
403-455-7717
Investor Relations
Allen Davidoff · 403-455-7727 · adavidoff@xortx.com
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »